Jamjoom Pharmaceuticals Factory Company (4015.SR)

SAR 157.4

(-0.51%)

Annual Balance Sheets

(In SAR)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 1.65 Billion 1.4 Billion 1.43 Billion 1.49 Billion 1.28 Billion 1.2 Billion
Total Current Assets 906.7 Million 688.08 Million 699.66 Million 846.71 Million 735.23 Million 690.01 Million
Cash And Short Term Investments 289.43 Million 146.29 Million 113.23 Million 235.72 Million 199.49 Million 175.26 Million
Cash and Cash Equivalents 284.27 Million 141.18 Million 112.62 Million 235.54 Million 180.57 Million 147.01 Million
Short Term Investments 5.15 Million 5.11 Million 609.74 Thousand 177.16 Thousand 18.91 Million 28.24 Million
Net Receivables 381.81 Million 407.3 Million 449.83 Million 480.66 Million 425.56 Million 371.16 Million
Inventory 233.92 Million 131.86 Million 135.16 Million 129.19 Million 104.51 Million 138.14 Million
Other Current Assets 1.52 Million 2.61 Million 1.42 Million 1.12 Million 5.65 Million 5.43 Million
Total Non-Current Assets 747.46 Million 719.73 Million 732.62 Million 648.94 Million 548.39 Million 517.25 Million
Net PPE 698.29 Million 705.04 Million 713.86 Million 613.55 Million 506.42 Million 474.72 Million
Good Will And Intangible Assets 13.04 Million 14.43 Million 14.78 Million 16.53 Million 4.02 Million 4.55 Million
Good Will - - - - 2.07 Million 1.85 Million
Intangible Assets 13.04 Million 14.43 Million 14.78 Million 16.53 Million 1.95 Million 2.7 Million
Long-Term Investments 30.95 Million -4.86 Million 3.36 Million 3.65 Million 37.94 Million 37.94 Million
Tax Assets - - 609.74 Thousand - -1.00 20.64 Thousand
Other Non Current Assets 5.15 Million 5.11 Million -22.00 15.2 Million 1.00 -1.00
Other Assets - - - - 1.00 1.00
Total Liabilities 249.83 Million 191.55 Million 200.65 Million 316.59 Million 214.11 Million 207.48 Million
Total Current Liabilities 179.97 Million 126.99 Million 138.36 Million 239.07 Million 130.11 Million 118.69 Million
Account Payables 65.28 Million 39.38 Million 43.01 Million 45 Million 18.13 Million 14.99 Million
Tax Payables 25.5 Million 17.72 Million 19.74 Million 22.09 Million 17.17 Million 16.96 Million
Short Term Debt 245.8 Thousand 235.16 Thousand 249.05 Thousand 95.27 Million 16.27 Million 14 Million
Deferred Revenue 100.76 Million 84.13 Million 92.78 Million 96.07 Million 4.68 Million 9.94 Million
Other Current Liabilities 13.67 Million 3.23 Million 2.32 Million 2.71 Million 91.02 Million 79.76 Million
Total Non Current Liabilities 69.86 Million 64.56 Million 62.29 Million 77.52 Million 84 Million 88.78 Million
Long-Term Debt 2.15 Million 2.4 Million 1.71 Million 1.96 Million 17.74 Million 32.58 Million
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 67.7 Million 62.16 Million 60.57 Million 75.55 Million 66.26 Million 56.2 Million
Other Liabilities - - - - - -
Total Equity 1.4 Billion 1.21 Billion 1.23 Billion 1.17 Billion 1.06 Billion 999.77 Million
Stock Holders Equity 1.4 Billion 1.21 Billion 1.23 Billion 1.17 Billion 1.06 Billion 999.77 Million
Common Stock 700 Million 700 Million 100 Million 100 Million 100 Million 100 Million
Retained Earnings 744.85 Million 524.21 Million 1.11 Billion 1.06 Billion 949.85 Million 881.1 Million
Accumulated other comprehensive income -40.52 Million -7.95 Million 12.12 Million 16.27 Million 19.65 Million 18.66 Million
Common Stock Equity 1.4 Billion 1.21 Billion 1.23 Billion 1.17 Billion 1.06 Billion 999.77 Million
Capital Lease Obligation 2.4 Million 2.63 Million 1.96 Million 2.22 Million 2.22 Million -
Total Investments 36.11 Million 250.9 Thousand 3.97 Million 3.82 Million 56.86 Million 66.18 Million
Total Debt 2.4 Million 2.63 Million 1.96 Million 97.24 Million 36.24 Million 46.58 Million
Net Debt -281.87 Million -138.54 Million -110.66 Million -138.3 Million -144.32 Million -100.43 Million

Balance Sheet Charts